MGRL: Predicting Drug-Disease Associations Based on Multi-Graph Representation Learning

被引:16
作者
Zhao, Bo-Wei [1 ,2 ,3 ]
You, Zhu-Hong [1 ,2 ,3 ]
Wong, Leon [1 ,2 ,3 ]
Zhang, Ping [4 ]
Li, Hao-Yuan [5 ]
Wang, Lei [1 ,2 ,3 ]
机构
[1] Chinese Acad Sci, Xinjiang Tech Inst Phys & Chem, Urumqi, Peoples R China
[2] Univ Chinese Acad Sci, Beijing, Peoples R China
[3] Xinjiang Lab Minor Speech & Language Informat Pro, Urumqi, Peoples R China
[4] BaoJi Univ Arts & Sci, Sch Comp Sci, Baoji, Peoples R China
[5] China Univ Min & Technol, Sch Comp Sci & Technol, Xuzhou, Jiangsu, Peoples R China
基金
美国国家科学基金会; 国家重点研发计划;
关键词
drug; disease; drug repositioning; multi-graph representation learning; graph embedding;
D O I
10.3389/fgene.2021.657182
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Drug repositioning is an application-based solution based on mining existing drugs to find new targets, quickly discovering new drug-disease associations, and reducing the risk of drug discovery in traditional medicine and biology. Therefore, it is of great significance to design a computational model with high efficiency and accuracy. In this paper, we propose a novel computational method MGRL to predict drug-disease associations based on multi-graph representation learning. More specifically, MGRL first uses the graph convolution network to learn the graph representation of drugs and diseases from their self-attributes. Then, the graph embedding algorithm is used to represent the relationships between drugs and diseases. Finally, the two kinds of graph representation learning features were put into the random forest classifier for training. To the best of our knowledge, this is the first work to construct a multi-graph to extract the characteristics of drugs and diseases to predict drug-disease associations. The experiments show that the MGRL can achieve a higher AUC of 0.8506 based on five-fold cross-validation, which is significantly better than other existing methods. Case study results show the reliability of the proposed method, which is of great significance for practical applications.
引用
收藏
页数:8
相关论文
共 42 条
  • [1] Estimating the cost of new drug development: Is it really $802 million?
    Adams, CP
    Brantner, VV
    [J]. HEALTH AFFAIRS, 2006, 25 (02) : 420 - 428
  • [2] Enriched random forests
    Amaratunga, Dhammika
    Cabrera, Javier
    Lee, Yung-Seop
    [J]. BIOINFORMATICS, 2008, 24 (18) : 2010 - 2014
  • [3] Prediction of Drug-Target Interactions From Multi-Molecular Network Based on Deep Walk Embedding Model
    Chen, Zhan-Heng
    You, Zhu-Hong
    Guo, Zhen-Hao
    Yi, Hai-Cheng
    Luo, Gong-Xu
    Wang, Yan-Bin
    [J]. FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2020, 8
  • [4] The computational prediction of drug-disease interactions using the dual-network L2,1-CMF method
    Cui, Zhen
    Gao, Ying-Lian
    Liu, Jin-Xing
    Wang, Juan
    Shang, Junliang
    Dai, Ling-Yun
    [J]. BMC BIOINFORMATICS, 2019, 20 (1)
  • [5] The Comparative Toxicogenomics Database: update 2017
    Davis, Allan Peter
    Grondin, Cynthia J.
    Johnson, Robin J.
    Sciaky, Daniela
    King, Benjamin L.
    McMorran, Roy
    Wiegers, Jolene
    Wiegers, Thomas C.
    Mattingly, Carolyn J.
    [J]. NUCLEIC ACIDS RESEARCH, 2017, 45 (D1) : D972 - D978
  • [6] The price of innovation: new estimates of drug development costs
    DiMasi, JA
    Hansen, RW
    Grabowski, HG
    [J]. JOURNAL OF HEALTH ECONOMICS, 2003, 22 (02) : 151 - 185
  • [7] PREDICT: a method for inferring novel drug indications with application to personalized medicine
    Gottlieb, Assaf
    Stein, Gideon Y.
    Ruppin, Eytan
    Sharan, Roded
    [J]. MOLECULAR SYSTEMS BIOLOGY, 2011, 7
  • [8] node2vec: Scalable Feature Learning for Networks
    Grover, Aditya
    Leskovec, Jure
    [J]. KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, 2016, : 855 - 864
  • [9] Integrative Construction and Analysis of Molecular Association Network in Human Cells by Fusing Node Attribute and Behavior Information
    Guo, Zhen-Hao
    You, Zhu-Hong
    Yi, Hai-Cheng
    [J]. MOLECULAR THERAPY-NUCLEIC ACIDS, 2020, 19 : 498 - 506
  • [10] Construction and Comprehensive Analysis of a Molecular Association Network via lncRNA-miRNA-Disease-Drug-Protein Graph
    Guo, Zhen-Hao
    Yi, Hai-Cheng
    You, Zhu-Hong
    [J]. CELLS, 2019, 8 (08)